Splrometry evaluation of montelukast treatment results in children with bronchial asthma;Spirometryczna ocena wyików leczenia montelukastem u dzieci chorych na astmȩ oskrzelowa̧

Polski Merkuriusz Lekarski

Volumn 12, Issue 68, 2002, Pages 92-94

  Jung, Anna ^a   Kalicki, Boleslaw ^a   Zuber, Janusz ^a   Dadas, Ewa ^a   Straz Zebrowska, Ewa ^a  

^a Klin Pediat Nefrologii Dzieciecej   (Poland)

Author keywords

Asthma, leukotriene antagonists; Montelukast

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; ACETIC ACID DERIVATIVE; QUINOLINE DERIVATIVE;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; TREATMENT OUTCOME; VITAL CAPACITY; PATHOPHYSIOLOGY;

ACETATES; ADOLESCENT; ASTHMA; CHILD; FEMALE; HUMANS; MALE; QUINOLINES; SPIROMETRY; TREATMENT OUTCOME;

EID: 0036483045     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene receptor antagonist, in human plasma and bile
2. A multicentre study to assess the steroid-sparing potential of Accolate (zafirlukast)
3. Clinical evidence with montelukast in the management of chronic childhood asthma
4. Lukotriene modifiers in pediatric asthma management
5. Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females
6. 4 receptor antagonist, in humans
7. Comparison of the effects of intravenosus and oral montelukast on airway function: A double blind, placebo controlled, three period, crossover study in asthmatic patients
8. New perspectives for asthma treatment: Anti-leukotriene drugs
9. Antileukotrienes. Their use in pediatrics
10. Lung function improvement in asthma with cysteinyl leukotriene receptor antagonist
11. Leki przeciwleukotrienowe
12. Montelukast: A review of its therapeutic potential in persistent asthma
13. Role of leukotriene receptor antagonist in pediatric asthma
14. Montelukast for chronic asthma in 6 to 14 year old children, a randomized, double-blind trial
15. Wspólczesne wyzawania i niezaspokojone potrzeby w diagnostyce i leczeniu przewleklej astmy
16. Rola leukotrienów w zapaleniu i leki przeciwleukotrienowe
17. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchocondtriction
18. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroides in asthmatic patients
19. Oral montelukast, inhaled beclomathasone, and placebo for chronic asthma
20. Binding to cysteinyl-leukotriene receptors
21. Treatment with montelukast in children with asthma. Test trial
22. Tolerability of montelukast
23. Effects of montelukast (MK-0476), a potent cysteinyl leukotriene receptor antagonist, or bronchodilatation in asthmatic subjects treated with and without inhaled corticosteroids
24. Effect of antileukotrien in mild to moderate asthmatic patients
25. Leki antyleukotrienowe w leczeniu astmy oskrzelowej u dzieci
26. Montelukast added to budesonide in children with persistent asthma: A randomized, double-blind, crossover study
27. Leukotriene receptor antagonists in the treatment of asthma
28. Leukotriene activity modulation in asthma
29. Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years
30. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older